(2020) Recent drugs and vaccine candidates to tackle COVID-19. Journal of Life Science and Biomedicine. pp. 70-79. ISSN 2251-9939
Text
JLSB 10(6) 70-79, 2020-drugs and vaccine candidates to tackle COVID-19 .pdf - Published Version Download (643kB) |
Abstract
Introduction. The global devastating pandemic coronavirus disease 2019 (COVID-19) is a worldwide multisystemic infection caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has emerged as a menace to the global public health and countries economy. There is a crucial necessity for the suggestion of effective drugs to eliminate the virus outbreak. Several candidate drugs with existing emerging evidence try to offer a pharmacological strategy that may inhibit infection in COVID-19 patients. By, October 2020, scientists have nominated some reliable and safe types of coronavirus vaccines like Pfizer, Moderna, AstraZeneca, CureVac, CoronaVac, etc. that are effective and showed 95% to 90% protection, respectively. Aim. This review highlights important clinical and in vitro studies, uses of potent antiviral drugs and most recent vaccines against COVID-19 disease.
Item Type: | Article |
---|---|
Keywords: | Actemra, Antiviral medicines, ARCoV, AstraZeneca, ChulaCov19, CoronaVac, COVID-19, CureVac, CytoSorb, Ivermectin, Moderna, Oleandrin, Pfizer, Remdesivir, Ritonavir, Vaccines. |
Subjects: | Q Science > Q Science (General) R Medicine > R Medicine (General) R Medicine > RD Surgery |
Divisions: | Journal of Life Sciences and Biomedicine (JLSB) |
Page Range: | pp. 70-79 |
Journal or Publication Title: | Journal of Life Science and Biomedicine |
Journal Index: | Not Index |
Volume: | 10 |
Number: | 06 |
Publisher: | Scienceline Publications, Ltd |
Identification Number: | https://doi.org/10.51145/jlsb.2020.9 |
ISSN: | 2251-9939 |
Depositing User: | Dr. Zohreh Yousefi |
URI: | http://eprints.science-line.com/id/eprint/559 |
Actions (login required)
View Item |